Retroperitoneal and Mesenteric Liposarcomas
- Author(s)
- Siew, CCH; Apte, SS; Baia, M; Gyorki, DE; Ford, S; van Houdt, WJ;
- Details
- Publication Year 2022-07,Volume 31,Issue #3,Page 399-417
- Journal Title
- Surgical Oncology Clinics of North America
- Publication Type
- Review
- Abstract
- Retroperitoneal liposarcomas are a rare entity and are comprised mostly of the well-differentiated and dedifferentiated subtypes. Eight-year survival ranges from 30% to 80% depending on histologic subtype and grade. Surgery is the cornerstone of treatment and compartment resection is the current standard. Mesenteric liposarcomas are extremely rare and comprise more high-grade lesions, with poorer prognosis of 50% 5-year overall survival. They are managed with a similar aggressive surgical approach. This review presents the current management of retroperitoneal and mesenteric liposarcomas.
- Keywords
- Humans; *Liposarcoma/pathology/surgery; *Retroperitoneal Neoplasms/pathology/surgery; Dedifferentiated liposarcoma; Liposarcoma; Mesenteric liposarcoma; Retroperitoneal liposarcoma; Well-differentiated liposarcoma
- Department(s)
- Surgical Oncology
- PubMed ID
- 35715141
- Publisher's Version
- https://doi.org/10.1016/j.soc.2022.03.005
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-04-04 05:25:00
Last Modified: 2025-04-04 05:39:07